Even a seasoned user cannot cleanly read their own microdose, because three sources of noise sit between dose and impression and experience removes none of them: the active content of the material is usually unknown, sensitivity varies a lot between people, and tolerance can blunt repeated doses. [1] Peer-reviewed Psychedelics doi:10.1124/pr.115.011478 What experience adds is a confident interpretive habit — useful for describing sensations, dangerous for assigning their cause, because it makes misattribution feel authoritative. [2] Peer-reviewed Microdosing psychedelics: More questions than answers? An overview and suggestions for future research doi:10.1177/0269881119857204 Individual variability widens the range of plausible reads rather than narrowing it, so a single uncontrolled report is less informative, not more. [3] Systematic review The emerging science of microdosing: a systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field doi:10.1016/j.neubiorev.2022.104706 This article explains these variables; it is not dosing, scheduling, or medical advice.
This article explains complicating variables, not a dosing or cycling protocol. It explains tolerance as an interpretation problem — not guidance on how to adjust dose, schedule, or cycling. Tolerance and schedule decisions live in the protocols cluster and are linked, not advised on here.
Three layers of noise between dose and read
A microdoser is trying to infer an effect from an experience. Several things distort that inference, and none of them yields to experience:
First, dose uncertainty. With whole mushrooms especially, the amount of active compound in a given quantity of material is rarely known, so the input itself is fuzzy. Second, interindividual variability: people differ substantially in metabolism, receptor sensitivity, and baseline mood, so the same amount can land very differently in two bodies. [1] Peer-reviewed Psychedelics doi:10.1124/pr.115.011478 Third, tolerance: repeated exposure to a psychedelic can reduce its effect over time. Experience does not shrink any of these; it simply gives the user more confidence while reading a noisy signal.
Tolerance, tachyphylaxis, and cross-tolerance
Classic serotonergic psychedelics are notable for building tolerance quickly. The rapid, short-term blunting of response with repeated dosing is sometimes called tachyphylaxis, and it is one stated rationale for the non-dosing days built into common microdosing schedules. [1] Peer-reviewed Psychedelics doi:10.1124/pr.115.011478 Whether sub-perceptual doses engage these mechanisms to a meaningful degree is not well established, and that uncertainty is the point — it is a complicating variable, not a settled fact to dose around. [2] Peer-reviewed Microdosing psychedelics: More questions than answers? An overview and suggestions for future research doi:10.1177/0269881119857204
| Concept | What it describes | Why it complicates the read |
|---|---|---|
| Drug tolerance | Reduced response to the same dose over repeated use | The “same” dose may not feel the same over time |
| Tachyphylaxis | Rapid, short-term tolerance with classic psychedelics | A dose can land differently depending on recent use |
| Cross-tolerance | Tolerance to one drug lowering sensitivity to a related one | Recent use of LSD or psilocybin can blunt the other |
| Dose–response relationship | How effect scales with amount | At sub-perceptual amounts the relationship is poorly characterised |
Cross-tolerance is especially relevant to experienced users, since classic psychedelics like LSD and psilocybin show cross-tolerance with one another. Someone with recent or heavy use may find a given amount lands below expectation, which is one more reason a single dose’s felt intensity is a weak basis for any conclusion. [1] Peer-reviewed Psychedelics doi:10.1124/pr.115.011478 Knowledge drawn from full-dose tolerance does not translate neatly into microdosing schedules: receptor adaptation is relevant, but the timing and magnitude of adaptation at sub-perceptual levels are not well characterised. [2] Peer-reviewed Microdosing psychedelics: More questions than answers? An overview and suggestions for future research doi:10.1177/0269881119857204
A muted response is itself ambiguous. It does not prove that the amount was too low, that tolerance is present, or that the compound is inactive — it only shows that subjective response is difficult to interpret. Tolerance can hide or distort a signal; it does not validate any particular reading of one.
| Variable | Why experience does not solve it |
|---|---|
| Unknown active content | Experience cannot measure alkaloid concentration |
| Individual sensitivity | Prior use does not standardise biology |
| Tolerance | A muted effect has several possible explanations |
| Expectation | Experience may intensify pattern recognition |
| Context | Mood, sleep, and stress still shift perception |
Why variability does not validate a personal read
A tempting move is to say: “the evidence is weak in general, but I know my own response.” Individual variability is genuine, but it cuts the other way. Wider variability means a single dose could plausibly produce many different impressions for reasons unrelated to the drug — mood, sleep, expectation, the specific batch — so an uncontrolled personal read becomes harder to interpret, not easier. The only thing that isolates a drug effect for an individual is blinding, and personal experience cannot manufacture that. When microdosers did blind themselves, much of the felt effect tracked belief rather than the molecule. [4] Observational Self-blinding citizen science to explore psychedelic microdosing doi:10.7554/eLife.62878
- Dose, body, and tolerance all add noise
- Unknown active content, individual variability, and tolerance sit between dose and impression. [1] Peer-reviewed Psychedelics doi:10.1124/pr.115.011478
- Cross-tolerance for the experienced
- Recent LSD or psilocybin use can blunt a related psychedelic, skewing the felt intensity. [1] Peer-reviewed Psychedelics doi:10.1124/pr.115.011478
- Variability widens, not validates
- More individual variability makes a single uncontrolled read less informative. [3] Systematic review The emerging science of microdosing: a systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field doi:10.1016/j.neubiorev.2022.104706
- Only blinding isolates the drug
- Self-blinding showed felt effects tracking belief, which personal experience cannot replicate. [4] Observational Self-blinding citizen science to explore psychedelic microdosing doi:10.7554/eLife.62878
Frequently asked questions
Why can't an experienced user simply judge their own microdose accurately?
Because several sources of noise sit between the dose and the read, and experience does not remove them. The active content of the material is usually unknown, individual sensitivity to psychedelics varies widely, and tolerance can blunt repeated doses. [1] Peer-reviewed Psychedelics doi:10.1124/pr.115.011478 An experienced user has a confident interpretive habit, which helps describe sensations but also makes it easier to assign ordinary fluctuations to ‘the microdose’. Confidence is not calibration, so a seasoned read can be wrong with great assurance.
What is tolerance, and how does it relate to microdosing?
Tolerance is a reduced response to the same dose after repeated exposure; the rapid, short-term form seen with classic psychedelics is sometimes called tachyphylaxis. Full perceptual doses of psychedelics build tolerance quickly, which is one reason most microdosing schedules include non-dosing days. [1] Peer-reviewed Psychedelics doi:10.1124/pr.115.011478 Whether sub-perceptual doses meaningfully engage these tolerance mechanisms is not well established, and this article does not prescribe any schedule — it explains why tolerance is a complicating variable, not a settled dosing rule.
What is cross-tolerance and why does it matter for experienced users?
Cross-tolerance is when tolerance to one drug reduces sensitivity to another acting through similar pathways; classic serotonergic psychedelics such as LSD and psilocybin show cross-tolerance with one another. [1] Peer-reviewed Psychedelics doi:10.1124/pr.115.011478 For someone with recent or heavy psychedelic use, this is one more reason a given amount may land differently than expected. It is a reason to be cautious about reading too much into a single dose’s intensity, not a basis for adjusting doses, which this article does not advise on.
Does individual variability mean my results are valid for me even if the evidence is weak?
Individual variability is real — people differ in metabolism, sensitivity, and baseline mood — but it does not rescue a self-report from the attribution problem. Variability widens the range of what any dose might do, which makes a single uncontrolled read less informative, not more. [4] Observational Self-blinding citizen science to explore psychedelic microdosing doi:10.7554/eLife.62878 To know whether a microdose is doing something for you specifically rather than expectation or chance, you would still need the kind of blinding that personal experience cannot supply. Reports are not outcomes, even individualised ones.
Can experienced users tell whether tolerance is affecting a microdose?
Not reliably from subjective impression alone. A muted or absent effect can reflect tolerance, but it can equally reflect low active content in the material, expectation, context, or natural day-to-day variation. [2] Peer-reviewed Microdosing psychedelics: More questions than answers? An overview and suggestions for future research doi:10.1177/0269881119857204 Because these explanations are hard to separate without blinding and a known dose, even a seasoned user cannot confidently single out tolerance as the cause of a weaker-feeling dose.